Restatement (Unaudited) - Consolidated Statements of Changes in Redeemable Perpetual Preferred Stock and Stockholders’ Equity (Deficit) (Details) - USD ($) $ in Thousands		3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Jan. 07, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		$ 110,368	$ 170,218	$ (69,205)	$ (69,205)	$ (69,205)	$ (69,205)	$ (80,899)	$ 305,151
Equity-based compensation		4,097	2,944	4,413	7,357	11,454	14,543	13,562	4,809
Issuance of stock, net (in shares)	50,000
Issuance of stock, net							216,078	104,764	145,532
Preferred cumulative dividends plus accretion		(12,257)	(12,182)	(11,606)	(23,788)	(36,045)	(48,054)	(8,226)
Net income (loss)		40,644	(5,024)	(25,937)	(30,961)	9,683	4,432	(50,403)	59,073
Other comprehensive income (loss)		(30,807)	(45,208)	56,675	11,467	(19,340)	8,425
Ending balance		$ 111,453	$ 110,368	$ 170,218	$ 110,368	$ 111,453	$ 124,281	$ (69,205)	$ (80,899)
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance (in shares)		413,000	400,000	350,000	350,000	350,000	350,000	0
Beginning balance		$ 293,974	$ 281,792	$ 237,462	$ 237,462	$ 237,462	$ 237,462	$ 0
Issuance of Series A Preferred, net of fees (in shares)				50,000	50,000	50,000	50,000	350,000
Issuance of Series A Preferred, net of fees				$ 32,724	$ 32,724	$ 32,724	$ 32,724	$ 229,799
Preferred cumulative dividends plus accretion (in shares)			13,000		13,000	13,000	19,000
Preferred cumulative dividends plus accretion		$ 12,257	$ 12,182	$ 11,606	$ 23,788	$ 36,045	$ 48,054	$ 8,226
Dividends paid (in shares)		(13,000)				(13,000)	(13,000)
Dividends paid		$ (18,670)				$ (18,670)	$ (18,670)
Ending balance (in shares)		400,000	413,000	400,000	413,000	400,000	406,000	350,000	0
Ending balance		$ 287,561	$ 293,974	$ 281,792	$ 293,974	$ 287,561	$ 299,570	$ 237,462	$ 0
Series A Preferred Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net		$ (592)	$ (380)	$ 215,878	$ 215,498	$ 214,906	$ (1,938)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)		150,279,000	150,174,000	135,027,000	135,027,000	135,027,000	135,027,000	126,994,000	0
Beginning balance		$ 150	$ 150	$ 135	$ 135	$ 135	$ 135	$ 127	$ 0
Equity-based compensation (in shares)		55,000	105,000			161,000	339,000	158,000
Issuance of stock, net (in shares)				15,147,000			15,147,000	7,875,000	7,000,000
Issuance of stock, net							$ 15	$ 8	$ 7
Ending balance (in shares)		150,334,000	150,279,000	150,174,000	150,279,000	150,334,000	150,513,000	135,027,000	126,994,000
Ending balance		$ 150	$ 150	$ 150	$ 150	$ 150	$ 150	$ 135	$ 127
Common Stock | Series A Preferred Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net (in shares)					15,252,000	15,146,000
Issuance of stock, net				15	$ 15	$ 15
Additional Paid-In Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		401,614	411,232	202,562	202,562	202,562	202,562	140,473	0
Equity-based compensation		4,097	2,944	4,413	7,357	11,454	14,543	13,562	1,412
Issuance of stock, net							216,063	104,756	145,525
Preferred cumulative dividends plus accretion		(12,257)	(12,182)	(11,606)	(23,788)	(36,045)	(48,054)	(8,226)
Ending balance		392,862	401,614	411,232	401,614	392,862	383,176	202,562	140,473
Additional Paid-In Capital | Series A Preferred Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net		(592)	(380)	215,863	215,483	214,891	(1,938)
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		(302,863)	(297,839)	(271,902)	(271,902)	(271,902)	(271,902)	(221,499)	0
Net income (loss)		40,644	(5,024)	(25,937)	(30,961)	9,683	4,432	(50,403)	(12,321)
Ending balance		(262,219)	(302,863)	(297,839)	(302,863)	(262,219)	(267,470)	(271,902)	(221,499)
Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		11,467	56,675	0	0	0	0	0
Other comprehensive income (loss)		(30,807)	(45,208)	56,675	11,467	(19,340)	8,425
Ending balance		(19,340)	11,467	56,675	11,467	(19,340)	8,425	0	$ 0
As Previously Reported
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		63,853	108,415	(69,205)	(69,205)	(69,205)	$ (69,205)
Equity-based compensation		4,097	2,944	4,413	7,357	11,454
Preferred cumulative dividends plus accretion		(12,257)	(12,182)	(11,606)	(23,788)	(36,045)
Net income (loss)		40,822	(5,226)	(22,054)	(27,280)	13,542
Other comprehensive income (loss)		(34,106)	(29,718)	(9,011)	(38,729)	(72,835)
Ending balance		$ 61,817	$ 63,853	$ 108,415	$ 63,853	$ 61,817		$ (69,205)
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance (in shares)		413,000	400,000	350,000	350,000	350,000	350,000
Beginning balance		$ 293,974	$ 281,792	$ 237,462	$ 237,462	$ 237,462	$ 237,462
Issuance of Series A Preferred, net of fees (in shares)				50,000	50,000	50,000
Issuance of Series A Preferred, net of fees				$ 32,724	$ 32,724	$ 32,724
Preferred cumulative dividends plus accretion (in shares)			13,000		13,000	13,000
Preferred cumulative dividends plus accretion		$ 12,257	$ 12,182	$ 11,606	$ 23,788	$ 36,045
Dividends paid (in shares)		(13,000)				(13,000)
Dividends paid		$ (18,670)				$ (18,670)
Ending balance (in shares)		400,000	413,000	400,000	413,000	400,000		350,000
Ending balance		$ 287,561	$ 293,974	$ 281,792	$ 293,974	$ 287,561		$ 237,462
As Previously Reported | Series A Preferred Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net		$ (592)	$ (380)	$ 215,878	$ 215,498	$ 214,906
As Previously Reported | Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)		150,279,000	150,174,000	135,027,000	135,027,000	135,027,000	135,027,000
Beginning balance		$ 150	$ 150	$ 135	$ 135	$ 135	$ 135
Equity-based compensation (in shares)		55,000	105,000			161,000
Issuance of stock, net (in shares)				15,147,000
Ending balance (in shares)		150,334,000	150,279,000	150,174,000	150,279,000	150,334,000		135,027,000
Ending balance		$ 150	$ 150	$ 150	$ 150	$ 150		$ 135
As Previously Reported | Common Stock | Series A Preferred Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net (in shares)					15,252,000	15,146,000
Issuance of stock, net				15	$ 15	$ 15
As Previously Reported | Additional Paid-In Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		401,614	411,232	202,562	202,562	202,562	202,562
Equity-based compensation		4,097	2,944	4,413	7,357	11,454
Preferred cumulative dividends plus accretion		(12,257)	(12,182)	(11,606)	(23,788)	(36,045)
Ending balance		392,862	401,614	411,232	401,614	392,862		202,562
As Previously Reported | Additional Paid-In Capital | Series A Preferred Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock, net		(592)	(380)	215,863	215,483	214,891
As Previously Reported | Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		(299,182)	(293,956)	(271,902)	(271,902)	(271,902)	(271,902)
Net income (loss)		40,822	(5,226)	(22,054)	(27,280)	13,542
Ending balance		(258,360)	(299,182)	(293,956)	(299,182)	(258,360)		(271,902)
As Previously Reported | Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		(38,729)	(9,011)	0	0	0	0
Other comprehensive income (loss)		(34,106)	(29,718)	(9,011)	(38,729)	(72,835)
Ending balance		(72,835)	(38,729)	(9,011)	(38,729)	(72,835)		0
Restatement Adjustments
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		46,515	61,803	0	0	0	$ 0
Net income (loss)		(178)	202	(3,883)	(3,681)	(3,859)
Other comprehensive income (loss)		3,299	(15,490)	65,686	50,196	53,495
Ending balance		$ 49,636	$ 46,515	$ 61,803	$ 46,515	$ 49,636		$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance (in shares)		0	0	0	0	0	0
Beginning balance		$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Ending balance (in shares)		0	0	0	0	0		0
Ending balance		$ 0	$ 0	$ 0	$ 0	$ 0		$ 0
Restatement Adjustments | Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)		0	0	0	0	0	0
Beginning balance		$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Ending balance (in shares)		0	0	0	0	0		0
Ending balance		$ 0	$ 0	$ 0	$ 0	$ 0		$ 0
Restatement Adjustments | Additional Paid-In Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		0	0	0	0	0	0
Ending balance		0	0	0	0	0		0
Restatement Adjustments | Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		(3,681)	(3,883)	0	0	0	0
Net income (loss)		(178)	202	(3,883)	(3,681)	(3,859)
Ending balance		(3,859)	(3,681)	(3,883)	(3,681)	(3,859)		0
Restatement Adjustments | Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		50,196	65,686	0	0	0	$ 0
Other comprehensive income (loss)		3,299	(15,490)	65,686	50,196	53,495
Ending balance		$ 53,495	$ 50,196	$ 65,686	$ 50,196	$ 53,495		$ 0